Literature DB >> 14531746

Functional bowel disorders and irritable bowel syndrome in Europe.

M Delvaux1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14531746     DOI： 10.1046/j.0953-0673.2003.01728.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  6 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Functional bowel disorders in Iranian population using Rome III criteria.

Authors:  Majid Sorouri; Mohammad A Pourhoseingholi; Mohsen Vahedi; Azadeh Safaee; Bijan Moghimi-Dehkordi; Asma Pourhoseingholi; Manijeh Habibi; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

3.  Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome.

Authors:  Hamid Kalantari; Akhtar Taheri; Majid Yaran
Journal:  Adv Biomed Res       Date:  2015-05-11

Review 4.  Human Intestinal Barrier Function in Health and Disease.

Authors:  Julia König; Jerry Wells; Patrice D Cani; Clara L García-Ródenas; Tom MacDonald; Annick Mercenier; Jacqueline Whyte; Freddy Troost; Robert-Jan Brummer
Journal:  Clin Transl Gastroenterol       Date:  2016-10-20       Impact factor: 4.488

5.  Irritable bowel syndrome in women undergoing hysterectomy and tubular ligation.

Authors:  Manouchehr Khoshbaten; Manigheh Syah Melli; Monireh Jabar Fattahi; Nasrin Sharifi; Seyed Abolfazl Mostafavi; Mohamad Amin Pourhoseingholi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2011

6.  On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.

Authors:  P Ducrotte; J C Grimaud; M Dapoigny; S Personnic; V O'Mahony; M C Andro-Delestrain
Journal:  Int J Clin Pract       Date:  2013-10-21       Impact factor: 2.503
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.